Reactions 1680, p285 - 2 Dec 2017 Steroid-induced psychosis: case report A 23-year-old woman developed steroid-induced psychosis during treatment with prednisone [route, dosage not stated]. The woman presented due to syncope with acute blood loss secondary to menorrhagia. After the presentation, she was diagnosed with lupus, and she received prednisone. Shortly after the prednisone therapy, she developed acute onset of anxiety, insomnia and command auditory hallucinations [duration of treatment to reaction onset not stated]. The woman’s prednisone therapy was therefore stopped and risperidone was started. Remission was achieved for one day, but she again developed psychiatric symptoms due to a lupus flare. The woman’s prednisone therapy was restarted at a lower dose along with antipsychotic medication. Thereafter, a complete remission was achieved and psychosis symptoms disappeared. Author comment: "Patient was started on prednisone and shortly thereafter developed acute onset of command auditory hallucinations, anxiety, and insomnia." " In our case example, we achieved the right combination of prednisone and an antipsychotic; symptoms remitted and the patient was successfully treated." Lieb K, et al. Case report of neuropsychiatric lupus versus steroid-induced psychosis in a young female: Mechanisms and management. CNS Spectrums 22: 81 (plus poster) abstr. 132, No. 1, Feb 2017. Available from: URL: http:// doi.org/10.1017/S1092852916000900 [abstract] - USA 803284804 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud